Sunday, 25 August 2019

Australia News

  • Australia develops intelligent hi-res retinal camera

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: The Australian Government's Cooperative Research Center (CRC) Program is providing susbtantial amounts of funds to researchers in order to develop the Intelligent Retinal Camera ...Read more

  • IDT appoints Paul MacLeman as CEO

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: IDT Australia appointed Dr Paul MacLeman as CEO, effective April 15, 2013. Dr MacLeman was recently the CEO of Melbourne-based biotechnology company Genetic Technologies, where h...Read more

  • Obese children more prone to Asthma: Study

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Researchers from the UK and Australia proved in a study that excess weight and obesity among children was a major reason contributing to Australia's high rates of asthma. The st...Read more

  • Dr Brian McNamee to step down from CSL

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: After 23 years of being at the helm of CSL, Dr Brian McNamee will leave the firm in July 2013 and will be succeeded by Mr Paul Perreault, who is currently the president of CSL Be...Read more

  • Canada's investment giant enters Aus life science

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    On October 25, 2012, Canada-based international investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a high profile life sciences team. Canaccord Genu...Read more

  • Celgene's anti-cancer drug reactivates dormant HIV: Study

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: A study presented by Danish scientists at the AIDS 2014 conference, indicated that an anti-cancer drug made by US biotech firm Celgene could reactivate dormant HIV in patients, f...Read more

  • BioDiem expands antimicrobial profile

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agreement with Griffith University to expand the range of formulations of...Read more

  • Pharma companies set eyes on China

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

  • Alchemia cancer trial gets nod from drug safety board

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's phase III, double blind, randomized, pivotal ...Read more

  • Alchemia gets new CEO

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more

  • Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

  • What the future holds for the APAC CRO market?

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Indo-Aussie research to find ovarian cancer cure

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • Changes in PBS to help Aussies save $20 mn

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: The listings and price changes that came into effect in Australia this August through the Pharmaceutical Benefits Scheme (PBS) is said to see saving of $20 million a year. Furth...Read more

  • Intl anesthesia society appoints board members

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: SmartTots, a research initiative sponsored by International Anesthesia Research Society, a non-political medical society that supports anesthesia research and education, has appo...Read more

  • Australian firm registers 25 disease specific stem cell lines at NIH

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been successful in registering 25 of its disease specific embryonic pluripotent s...Read more

  • Trial begins for vaccine that builds gluten tolerance

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

  • Adhesive patch to deliver drugs

    Australia |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

    One of the promising alternative drug delivery technologies is a transdermal delivery platform called targeted pentration matrix (TPM). Australia-based Phosphagenics has been working to dev...Read more



Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls